Arrivo BioVentures.

PositionTRIANGLE BRIEFS: MORRISVILLE

Arrivo BioVentures secured $49 million to launch a drug-development company focused on treating conditions affected by the central nervous system. Ireland-based Jazz Pharmaceuticals is the lead investor in the financing, which...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT